🍂 Enjoy the Fall Season! 🍂
MindTheDesk

AstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows

Global - Asia Archived • September 29, 2026 •
AstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows
Shares of Akeso surged after British drug maker AstraZeneca moved to advance the Chinese biotech firm’s flagship cancer drug, while a new deal from US giant Merck further underscored the sector’s global momentum amid easing fears of US curbs.
AstraZeneca on Tuesday announced a US$2 billion equity investment in Florida-headquartered Summit Therapeutics, which holds the exclusive rights to develop and commercialise Akeso’s immunotherapy drug ivonescimab outside China.
Summit and AstraZeneca would...
Source: South China Morning Post | https://www.scmp.com/rss/91/feed - Read Original
"House Plans for Structures New and Old"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Get your business promoted today."
"We build AI or anything ICST"